|Articles|March 4, 2009
Low-dose proton beam therapy for circumscibed choroidal hemangiomas
Low-dose proton beam therpay for circumscibed choroidal hemangiomas
Advertisement
LONG-TERM RESULTS OF LOW-DOSE PROTON BEAM THERAPY FOR CIRCUMSCRIBED CHOROIDAL HEMANGIOMAS, from the February issue of Retina.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
SubscribeAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA grants RMAT designation to Emmecell's EO2002 for corneal endothelial disease
2
NeuroOp Guru: What a big data study reveals about NAION and stroke risk
3
Port Delivery System Therapies in Retinal Vascular Diseases
4
Opus Genetics reaches FDA alignment on phase 3 registrational design for OPGx-LCA5 gene therapy
5


















